Cargando…
P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430797/ http://dx.doi.org/10.1097/01.HS9.0000846600.20422.ca |
| _version_ | 1784779875714859008 |
|---|---|
| author | Spencer, A. Moreau, P. Mateos, M.-V. Goldschmidt, H. Suzuki, K. Levin, M.-D. Sonneveld, P. Yoon, S.-S. Usmani, S. Z. Weisel, K. Reece, D. Ahmadi, T. Pei, H. Garvin Mayo, W. Gai, X. Carey, J. Carson, R. Dimopoulos, M. A. |
| author_facet | Spencer, A. Moreau, P. Mateos, M.-V. Goldschmidt, H. Suzuki, K. Levin, M.-D. Sonneveld, P. Yoon, S.-S. Usmani, S. Z. Weisel, K. Reece, D. Ahmadi, T. Pei, H. Garvin Mayo, W. Gai, X. Carey, J. Carson, R. Dimopoulos, M. A. |
| author_sort | Spencer, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430797 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94307972022-08-31 P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY Spencer, A. Moreau, P. Mateos, M.-V. Goldschmidt, H. Suzuki, K. Levin, M.-D. Sonneveld, P. Yoon, S.-S. Usmani, S. Z. Weisel, K. Reece, D. Ahmadi, T. Pei, H. Garvin Mayo, W. Gai, X. Carey, J. Carson, R. Dimopoulos, M. A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430797/ http://dx.doi.org/10.1097/01.HS9.0000846600.20422.ca Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Spencer, A. Moreau, P. Mateos, M.-V. Goldschmidt, H. Suzuki, K. Levin, M.-D. Sonneveld, P. Yoon, S.-S. Usmani, S. Z. Weisel, K. Reece, D. Ahmadi, T. Pei, H. Garvin Mayo, W. Gai, X. Carey, J. Carson, R. Dimopoulos, M. A. P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY |
| title | P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY |
| title_full | P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY |
| title_fullStr | P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY |
| title_full_unstemmed | P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY |
| title_short | P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY |
| title_sort | p933: daratumumab (d) in combination with vd or d-rd in relapsed or refractory multiple myeloma: subgroup analysis of castor and pollux studies in patients with early or late relapse after initial therapy |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430797/ http://dx.doi.org/10.1097/01.HS9.0000846600.20422.ca |
| work_keys_str_mv | AT spencera p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT moreaup p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT mateosmv p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT goldschmidth p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT suzukik p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT levinmd p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT sonneveldp p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT yoonss p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT usmanisz p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT weiselk p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT reeced p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT ahmadit p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT peih p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT garvinmayow p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT gaix p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT careyj p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT carsonr p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy AT dimopoulosma p933daratumumabdincombinationwithvdordrdinrelapsedorrefractorymultiplemyelomasubgroupanalysisofcastorandpolluxstudiesinpatientswithearlyorlaterelapseafterinitialtherapy |